Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts

Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts

Neurodegenerative diseases such as Parkinson’s disease (PD) are manifested by inclusion bodies of alpha-synuclein (α-syn) also called α-synucleinopathies. Detection of these inclusions is thus far only possible by histological examination of postmortem brain tissue. The possibility of non-invasively...

Full description

Bibliographic Details
Main Authors: Špela Korat, Natasha Shalina Rajani Bidesi, Federica Bonanno, Adriana Di Nanni, Anh Nguyên Nhât Hoàng, Kristina Herfert, Andreas Maurer, Umberto Maria Battisti, Gregory David Bowden, David Thonon, Daniëlle Vugts, Albert Dirk Windhorst, Matthias Manfred Herth
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmaceuticals
Subjects:
alpha-synuclein
imaging
synucleinopathies
positron emission tomography
Online Access:https://www.mdpi.com/1424-8247/14/9/847

Internet

https://www.mdpi.com/1424-8247/14/9/847

Similar Items